{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:15:09Z","timestamp":1757780109108},"reference-count":35,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.imlet.2013.04.006","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T20:27:29Z","timestamp":1367353649000},"page":"121-125","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The expression of human leukocyte antigen G (HLA-G) is associated with sacroiliitis stages of ankylosing spondylitis"],"prefix":"10.1016","volume":"152","author":[{"given":"Jian-bo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-mian","family":"Yie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7809","key":"10.1016\/j.imlet.2013.04.006_bib0005","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","article-title":"Ankylosing spondylitis and HL-A27","volume":"1","author":"Brewerton","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2013.04.006_bib0010","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJM197304052881403","article-title":"High association of an HL-A antigen, W27, with ankylosing spondylitis","volume":"288","author":"Schlosstein","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1016\/j.imlet.2013.04.006_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1258\/jrsm.97.1.10","article-title":"The ramifications of HLA-B27","volume":"97","author":"Sheehan","year":"2004","journal-title":"J R Soc Med"},{"key":"10.1016\/j.imlet.2013.04.006_bib0020","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/kei047","article-title":"The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis","volume":"44","author":"Zochling","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2013.04.006_bib0025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nri1984","article-title":"Regulation of immune tolerance by anti-inflammatory neuropeptides","volume":"7","author":"Gonzalez-Rey","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.imlet.2013.04.006_bib0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.it.2007.11.005","article-title":"HLA-G: from biology to clinical benefits","volume":"29","author":"Carosella","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1016\/j.imlet.2013.04.006_bib0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1530\/ror.0.0020007","article-title":"HLA-G and pregnancy","volume":"2","author":"Le Bouteiller","year":"2007","journal-title":"Rev Reprod"},{"key":"10.1016\/j.imlet.2013.04.006_bib0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1399-0039.2006.00757.x","article-title":"Research on HLA-G: an update","volume":"69","author":"Favier","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.imlet.2013.04.006_bib0045","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.humimm.2006.03.023","article-title":"Soluble HLA-G in rheumatoid arthritis","volume":"67","author":"Verbruggen","year":"2006","journal-title":"Hum Immunol"},{"key":"10.1016\/j.imlet.2013.04.006_bib0050","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jaci.2004.11.031","article-title":"Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma","volume":"115","author":"Rizzo","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.imlet.2013.04.006_bib0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1191\/1352458506ms1241oa","article-title":"Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis","volume":"12","author":"Fainardi","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.imlet.2013.04.006_bib0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jneuroim.2004.09.016","article-title":"Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-\u03b2 in vitro and in vivo: rationale for the therapy of multiple sclerosis","volume":"159","author":"Mitsdoerffer","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.imlet.2013.04.006_bib0065","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/db05-0731","article-title":"The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G","volume":"55","author":"Cirulli","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.imlet.2013.04.006_bib0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jneuroim.2007.05.008","article-title":"Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G","volume":"187","author":"Airas","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.imlet.2013.04.006_bib0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/rheumatology\/kep360","article-title":"Human leukocyte antigen-G in ankylosing spondylitis and the response after tumour necrosis factor \u2013 a blocker therapy","volume":"49","author":"Chen","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 3","key":"10.1016\/j.imlet.2013.04.006_bib0080","first-page":"9","article-title":"Staging of patients with ankylosing spondylitis: a preliminary proposal","volume":"61","author":"Braun","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.imlet.2013.04.006_bib0085","first-page":"980","article-title":"Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis","volume":"26","author":"Spoorenberg","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.imlet.2013.04.006_bib0090","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/rheumatology\/30.5.330","article-title":"The relationship of clinical and laboratory measurements to radiological change in ankylosing spondylitis","volume":"30","author":"Taylor","year":"1991","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.imlet.2013.04.006_bib0095","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria","volume":"27","author":"Van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 3","key":"10.1016\/j.imlet.2013.04.006_bib0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/ard.61.suppl_3.iii8","article-title":"Ankylosing spondylitis: an overview","volume":"61","author":"Sieper","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.imlet.2013.04.006_bib0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cyto.990180106","article-title":"An optimized method for routine HLA-B27 screening using flow cytometry","volume":"18","author":"Hulstaert","year":"1994","journal-title":"Cytometry"},{"key":"10.1016\/j.imlet.2013.04.006_bib0110","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/modpathol.3800751","article-title":"Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer","volume":"20","author":"Ye","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.imlet.2013.04.006_bib0115","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1245\/s10434-007-9464-y","article-title":"Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma","volume":"14","author":"Yie","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.imlet.2013.04.006_bib0120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1399-0039.2011.01716.x","article-title":"Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer","volume":"78","author":"Cao","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.imlet.2013.04.006_bib0125","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1245\/s10434-009-0891-9","article-title":"HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro","volume":"17","author":"He","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.imlet.2013.04.006_bib0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2567.2000.00109.x","article-title":"HLA-G has a concentration-dependent effect on the generation of an allo-CTL response","volume":"101","author":"Kapasi","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2013.04.006_bib0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-1759(02)00295-8","article-title":"A simple method for the determination of dissociation constants by displacement ELISA","volume":"270","author":"Orosz","year":"2002","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.imlet.2013.04.006_bib0140","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1399-0039.2008.01037.x","article-title":"HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus","volume":"71","author":"Rizzo","year":"2008","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.imlet.2013.04.006_bib0145","series-title":"Cellular and molecular immunology","first-page":"216","author":"Abbas","year":"2005"},{"key":"10.1016\/j.imlet.2013.04.006_bib0150","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/art.1780381105","article-title":"Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both?","volume":"38","author":"Sieper","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2013.04.006_bib0155","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/intimm\/dxh270","article-title":"The involvement of NK cells in ankylosing spondylitis","volume":"17","author":"Azuz-Lieberman","year":"2005","journal-title":"Int Immunol"},{"key":"10.1016\/j.imlet.2013.04.006_bib0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.humimm.2012.11.024","article-title":"HLA-G may predict the disease course in patients with early rheumatoid arthritis","volume":"74","author":"Rizzo","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.imlet.2013.04.006_bib0165","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10875-010-9496-0","article-title":"Expression and functional role of HLA-G in immune cells from patients with systemic lupus erythematosus","volume":"31","author":"Monsiv\u00e1is-Urenda","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.imlet.2013.04.006_bib0170","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1044-579X(03)00024-5","article-title":"HLA-G and IL-10 expression in human cancer \u2013 different stories with the same message","volume":"13","author":"Urosevic","year":"2003","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.imlet.2013.04.006_bib0175","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/1529-0131(200106)44:6<1396::AID-ART233>3.0.CO;2-A","article-title":"Is disease severity in ankylosing spondylitis genetically determined?","volume":"44","author":"Hamersma","year":"2001","journal-title":"Arthritis Rheum"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524781300059X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524781300059X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T11:52:47Z","timestamp":1539690767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016524781300059X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S016524781300059X"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2013.04.006","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The expression of human leukocyte antigen G (HLA-G) is associated with sacroiliitis stages of ankylosing spondylitis","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2013.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}